Search results
What Is Severe Asthma?
Health via Yahoo News· 3 weeks agoRealPeopleGroup / Getty Images Medically reviewed by Reza Samad, MD Severe asthma is the term used for asthma that is difficult to treat and control....
Severe Asthma Patients on Ways Their Doctors Could Improve Treatment
Time via Yahoo News· 1 year agoCredit - shutjane—Getty Images Approximately 25 million people in the U.S. have asthma, according to...
How Is Asthma Diagnosed?
Health via Yahoo News· 11 months agoAsthma is a chronic lung disease characterized by inflammation and narrowing of the airways, causing symptoms like shortness of breath, wheezing,...
Flovent asthma inhalers pulled from shelves and replaced with generic Jan. 1
USA TODAY via Yahoo News· 4 months agoOne of the most widely-used asthma and breathing treatments for over 20 years is being taken off the...
What's Up Doc? No cure for EPGA - Churg-Strauss syndrome - but treatments are available
The Metrowest Daily News via Yahoo News· 2 years agoQ: Even though I am almost 40, last week I was hospitalized for asthma for the first time in my...
Regeneron (REGN), Sanofi's Dupixent Succeeds in 2nd COPD Study
Zacks via Yahoo Finance· 5 months agoRegeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced positive study data on the...
Flovent Inhalers Discontinued—Here's What People With Asthma Should Know
Health via Yahoo News· 4 months agoAs of January 1, drug manufacturer GSK has discontinued its Flovent asthma inhaler, and is producing...
AstraZeneca drug fails one main goal in study of chronic immune disease
Reuters via Yahoo News· 1 year agoThe condition, eosinophilic esophagitis, is characterised by inflammation and damage to the...
Eczema to hay fever: The ‘allergic march’ shows how allergies can progress in kids
TODAY via Yahoo News· 9 months agoEczema in young babies could be a sign that a child will go on to develop more allergies. New...
Sanofi (SNY), Regeneron Dupixent sBLA Accepted for FDA Review
Zacks via Yahoo Finance· 1 year agoSanofi SNY announced that the supplemental biologics license application (sBLA) for the label...
